Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Braithwaite

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|November 20, 2022
Provision of electroconvulsive therapy in ItalyRichard Braithwaite
Journal of Psychiatric Research|January 17, 2026
Association between pulse width and clinical response to electroconvulsive therapyRichard Braithwaite, Ana Jelovac
Molecular Psychiatry|June 22, 2026
Re-evaluating response rates, time to reorientation and inadequate seizure duration in magnetic seizure therapy for schizophrenia and major depressionAna Jelovac, Richard Braithwaite
Bjpsych Bulletin|May 12, 2021
Effects of the COVID-19 pandemic on provision of electroconvulsive therapyRichard Braithwaite, Robert Chaplin, Vimal Sivasanker
The British Journal of Psychiatry : the Journal of Mental Science|November 11, 2025
Advancing ketamine in the treatment hierarchy for refractory depression: commentary, Jelovac et alAna Jelovac, Richard Braithwaite, Declan M McLoughlin
The American Journal of Psychiatry|June 1, 2026
Relapse Prevention After Successful ECT for Depression: The Role of Lithium and Continuation/Maintenance ECTCharles H Kellner, Ana Jelovac, Richard Braithwaite
Bjpsych International|April 9, 2026
Improving the delivery of electroconvulsive therapy in the West Bank, PalestineRichard Braithwaite, Nadia Taysir Dabbagh, Ibrahim Ikhmayyes, et al.
Psychological Medicine|August 28, 2025
Continuation electroconvulsive therapy combined with pharmacotherapy for depression relapse prevention: A systematic review and meta-analysisAna Jelovac, Richard Braithwaite, Charles H Kellner, et al.
The Journal of ECT|May 27, 2020
Successful Electroconvulsive Therapy in a Patient With Confirmed, Symptomatic COVID-19Richard Braithwaite, Hollie L McKeown, Victor J Lawrence, et al.
The Lancet. Psychiatry|October 25, 2025
Ketamine versus ECT for major depression: flawed evidence baseRichard Braithwaite, Ana Jelovac, Charles H Kellner, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The British Journal of Psychiatry : the Journal of Mental Science|November 20, 2022
Provision of electroconvulsive therapy in ItalyRichard Braithwaite
Journal of Psychiatric Research|January 17, 2026
Association between pulse width and clinical response to electroconvulsive therapyRichard Braithwaite, Ana Jelovac
Molecular Psychiatry|June 22, 2026
Re-evaluating response rates, time to reorientation and inadequate seizure duration in magnetic seizure therapy for schizophrenia and major depressionAna Jelovac, Richard Braithwaite
Bjpsych Bulletin|May 12, 2021
Effects of the COVID-19 pandemic on provision of electroconvulsive therapyRichard Braithwaite, Robert Chaplin, Vimal Sivasanker
The British Journal of Psychiatry : the Journal of Mental Science|November 11, 2025
Advancing ketamine in the treatment hierarchy for refractory depression: commentary, Jelovac et alAna Jelovac, Richard Braithwaite, Declan M McLoughlin
The American Journal of Psychiatry|June 1, 2026
Relapse Prevention After Successful ECT for Depression: The Role of Lithium and Continuation/Maintenance ECTCharles H Kellner, Ana Jelovac, Richard Braithwaite
Bjpsych International|April 9, 2026
Improving the delivery of electroconvulsive therapy in the West Bank, PalestineRichard Braithwaite, Nadia Taysir Dabbagh, Ibrahim Ikhmayyes, et al.
Psychological Medicine|August 28, 2025
Continuation electroconvulsive therapy combined with pharmacotherapy for depression relapse prevention: A systematic review and meta-analysisAna Jelovac, Richard Braithwaite, Charles H Kellner, et al.
The Journal of ECT|May 27, 2020
Successful Electroconvulsive Therapy in a Patient With Confirmed, Symptomatic COVID-19Richard Braithwaite, Hollie L McKeown, Victor J Lawrence, et al.
The Lancet. Psychiatry|October 25, 2025
Ketamine versus ECT for major depression: flawed evidence baseRichard Braithwaite, Ana Jelovac, Charles H Kellner, et al.
Pageof 3